I-ELCAP Mission & History
To achieve early diagnosis, treatment, and ultimate cure of lung cancer through the rapid dissemination and advancement of research among a diversified, collaborative network.
Who we are
I-ELCAP is an international, collaborative group consisting of experts on lung cancer and related issues from around the world.
To find out about how to become a member, click here.
In 1991, a group of physicians from Cornell University Medical Center (now Weill Medical College of Cornell University) joined forces with specialists from other institutions to find a common research goal. They found this goal in early lung cancer detection, and the promise offered by helical CT imaging. In 1992, ELCAP (Early Lung Cancer Action Program) was born.
ELCAP, now I-ELCAP, quickly attracted other institutions. Today's full member list can be viewed here.
Numerous publications document the findings of the I-ELCAP members' work. Among these findings:
- Curability of Stage I lung cancers is 80-90%
- Annual CT screening allows at least 80% of lung cancers to be diagnosed at Stage I
- CT screening creates a counseling opportunity that results in greater smoking cessation
- Costs of CT screening for lung cancer compare favorably with breast, cervical, and colon cancer screenings
Research is ongoing, incorporating larger pools of patient data to reaffirm early findings and suggest new directions for future research and recommendations.
Sign up below to join our email list and receive notice of site updates and other I-ELCAP news.
Have questions? Contact us by email, telephone or mail.
If you're ready to talk about getting screened, or to make an appointment with a doctor in your area, search our list of member sites to find the location nearest you.
I-ELCAP would like thank Idologic, Inc., for its donation of hosting and support services.